|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 269.70 CHF | -1.06% |
|
+0.56% | +5.56% |
| Jun. 13 | Eli Lilly's experimental obesity drug shows over 11% weight loss in early trial | RE |
| Jun. 11 | US FDA approves Nuvation Bio's rare lung cancer drug | RE |
EPS & Dividend: Roche Holding AG
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 9.1 | 9.3 | 9.5 | 9.6 | 9.7 | 9.879 | 10.14 | 10.4 |
| Rate of return | 2.94% | 2.45% | 3.27% | 3.93% | 3.8% | 3.66% | 3.76% | 3.86% |
| EPS 2 | 16.52 | 16.2 | 15.37 | 14.31 | 10.31 | 18.27 | 19.8 | 21.22 |
| Distribution rate | 55.1% | 57.4% | 61.8% | 67.1% | 94.1% | 54.1% | 51.2% | 49% |
| Reference price 2 | 309.00 | 379.10 | 290.50 | 244.50 | 255.50 | 269.70 | 269.70 | 269.70 |
| Nbr of stocks (in thousands) | 854,642 | 800,952 | 854,579 | 798,652 | 796,789 | 795,401 | - | - |
| Announcement Date | 2/4/21 | 2/3/22 | 2/2/23 | 2/1/24 | 1/30/25 | - | - | - |
1CHF in Million2CHF
Estimates
Past dividends: Roche Holding AG
| 2025-03-26 | Annual 9.7 CHF |
| 2024-03-13 | Annual 9.6 CHF |
| 2023-03-15 | Annual 9.5 CHF |
| 2022-03-16 | Annual 9.3 CHF |
| 2021-03-17 | Annual 9.1 CHF |
| 2020-03-18 | Annual 9 CHF |
| 2019-03-06 | Annual 8.7 CHF |
| 2018-03-14 | Annual 8.3 CHF |
| 2017-03-15 | Annual 8.2 CHF |
| 2016-03-02 | Annual 8.1 CHF |
Upcoming events: Roche Holding AG
More events
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
| 3.66% | 3.76% | 14.76x | 5.55x | 3.6x | ||
| 0.73% | 0.82% | 38.64x | 28.06x | 12.76x | ||
| 3.33% | 3.42% | 15.05x | 5.12x | 4.19x | ||
| 2.56% | 3.01% | 19.62x | 11.33x | 7.05x | ||
| 3.42% | 3.59% | 28.57x | 46.84x | 6.55x | ||
| 3.3% | 3.43% | 17.22x | 5.11x | 4.61x | ||
| 2.15% | 2.26% | 23.39x | 5.17x | 4.35x | ||
| 3.94% | 4.14% | 10.47x | 3.71x | 3.39x | ||
| 3.25% | 3.41% | 21.88x | 17.57x | 5.78x | ||
| 6.96% | 7.11% | 11.53x | 1.54x | 2.85x | ||
| Average | 3.33% | 3.5% | 20.11x | 13.00x | 5.51x | |
| Weighted average by Cap. | 2.76% | 2.92% | 23.45x | 16.45x | 6.82x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
